Can radioiodine be administered effectively and safely to a patient with severe chronic kidney disease?
- 22 May 2014
- journal article
- review article
- Published by Wiley in Clinical Endocrinology
- Vol. 81 (2) , 169-174
Abstract
Chronic kidney disease is an increasingly widespread problem. The progression of renal failure is associated with the development of various hormonal disorders, including those affecting the thyroid gland. The prevalence of multinodular goitre and differentiated thyroid cancer increases significantly in patients with renal failure. However, radioiodine treatment in patients with severe chronic kidney disease gives rise to a number of difficulties. The only conclusions regarding this treatment thus far have been derived from single case studies. It seems that prospective controlled studies can contribute to the creation of standards for radioiodine treatment in patients with various stages of chronic kidney disease, while maintaining the safety of such treatment for both patients and medical staff. This review gives the response to the question how nowadays to treat the patients with severe chronic kidney disease with radioiodine.Keywords
This publication has 31 references indexed in Scilit:
- Prevalence of Clinical and Subclinical Thyroid Disease in a Peritoneal Dialysis PopulationPeritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis, 2012
- Hemodialysis of chronic kidney failure patients requiring ablative radioiodine therapyKidney International, 2008
- Clinicopathological Characteristics of Thyroid Cancer in Patients on Dialysis for End-Stage Renal DiseaseThyroid®, 2008
- Radiation Safety Protocol for High Dose 131I Therapy of Thyroid Carcinoma in Patients on Hemodialysis for Chronic Renal FailureHealth Physics, 2007
- Iodine-131 Treatment of Thyroid Papillary Carcinoma in Patients Undergoing Dialysis for Chronic Renal Failure: A Dosimetric MethodThyroid®, 2001
- Successful Treatment of a Patient with Graves' Disease on Hemodialysis Complicated by Antithyroid Drug-Induced Granulocytopenia and Angina PectorisThyroid®, 1997
- Radioiodine Treatment of Thyroid Carcinoma in Patients on Maintenance HemodialysisThyroid®, 1996
- Management of Thyroid Papillary Carcinoma With Radioiodine in a Patient With End Stage Renal Disease on HemodialysisClinical Nuclear Medicine, 1994
- 131I treatment of thyroid papillary carcinoma in a patient with renal failureCancer, 1990
- Iodine 131 ablation therapy for a patient on maintenance haemodialysisBritish Journal of Radiology, 1981